HaystackAnalytics Launches' TB One' to Enhance TB Diagnosis in India

'TB One' includes a pre-sequencing kit for Whole Genome Sequencing (WGS), access to HaystackAnalytics' patented clinical reporting software 'Omega TB,' and on-demand access to 2GB of sequencing data.

Mumbai-based healthtech startup HaystackAnalytics has introduced 'TB One,' a Make-in-India solution designed to enhance tuberculosis (TB) diagnosis using Next-Generation Sequencing (NGS) technology.

The solution aims to improve TB management by providing comprehensive drug resistance profiling and detailed clinical insights.

'TB One' includes a pre-sequencing kit for Whole Genome Sequencing (WGS), access to HaystackAnalytics' patented clinical reporting software 'Omega TB,' and on-demand access to 2GB of sequencing data.

This all-in-one solution enables diagnostic labs and hospitals to upgrade to NGS-based TB testing without requiring major infrastructure changes.

The Omega TB software generates a standardized clinical report covering resistance to 18 anti-TB drugs, mixed infections, non-tuberculous mycobacteria (NTM), and heteroresistance.

This ensures healthcare providers receive precise, data-driven insights to tailor treatment strategies and improve patient outcomes.

Dr Anirvan Chatterjee, Co-founder and CEO of HaystackAnalytics, and Dr. Rajendra Prasad unveiled the solution on March 19, 2025, at the Indian Council of Medical Research's (ICMR) India Innovation Summit.

The summit focused on pioneering solutions to eliminate TB in India and highlighted the importance of technological advancements in disease management.

Dr Chatterjee emphasized that 'TB One' makes genomics-based TB testing more accessible and scalable, enabling laboratories to conduct high-precision drug resistance profiling without extensive modifications to existing systems.

Simplified & Scalable Genomic Testing

'TB One' simplifies the genomic testing process by allowing laboratories to prepare a ready-to-sequence library from TB DNA.

This advancement allows hospitals and diagnostic labs to integrate genomic technology into their workflows, enhancing efficiency and diagnostic accuracy.

By equipping healthcare providers with reliable clinical data, HaystackAnalytics aims to strengthen India's fight against TB and improve early detection and treatment outcomes.

'TB One' aligns with the company's mission to make genomics accessible, applicable, and affordable across India's healthcare ecosystem.

Stay tuned for more such updates on Digital Health News.